POPULARITY
19 episodes with adverse events
9 episodes with adverse events
7 episodes with adverse events
4 episodes with adverse events
6 episodes with adverse events
7 episodes with adverse events
9 episodes with adverse events
6 episodes with adverse events
4 episodes with adverse events
6 episodes with adverse events
2 episodes with adverse events
7 episodes with adverse events
4 episodes with adverse events
5 episodes with adverse events
3 episodes with adverse events
![VERITAS w/ Mel Fabregas | [Non-Member Feed] | Subscribe at http://www.VeritasRadio.com/subscribe.html to listen to all parts.](https://ivyfm.s3.amazonaws.com/i320/347516.jpg)
3 episodes with adverse events
5 episodes with adverse events
2 episodes with adverse events
6 episodes with adverse events
5 episodes with adverse events
3 episodes with adverse events
2 episodes with adverse events
3 episodes with adverse events
2 episodes with adverse events
5 episodes with adverse events
4 episodes with adverse events
3 episodes with adverse events
In this episode of Right to Life Radio, John Gerardi dives into a groundbreaking study exposing the abortion pill's dangers, revealing an 11% rate of serious adverse events—far higher than the FDA's claims. Joined by Linda Talia, the show shares poignant "Stories from the Sidewalk," capturing the heartbreak and hope of ministering outside Planned Parenthood. Jonathan Keller breaks down California's push to shield abortion pill access, spotlighting legislative gaslighting despite hard data. It's a raw look at life, science, and politics colliding.
In this episode Laura Sigman, MD, FAAP, discusses having conversations with patients about adverse medical events. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Rebekah Levine Coley, PhD, about new trends in adolescents' risky behaviors. For resources go to aap.org/podcast.
In this episode of Nurse Converse, Maggie Ortiz and RaDonda Vaught explore the lasting impact of RaDonda's case, focusing on the Board of Nursing's role, the legal risks nurses face, and the complexities of due process following medical errors. They discuss the urgent need for accountability, legal education, and support for nurses navigating an often opaque regulatory system—all while keeping patient safety at the center. Join us for a candid conversation about the legal challenges nurses face and what must change to better protect both nurses and patients.Jump Ahead to Listen:[01:41] Boards of nursing investigations.[04:16] Types of law for nurses.[09:54] Medication-related patient harm.[12:13] Medication administration policy violation.[16:07] Legal rights for nurses.[20:14] Protecting the public vs. nurses.[25:03] Administrative law for nurses.[29:35] Oversight in nursing investigations.Connect with Maggie LinkedIn and on social media:Instagram: @advocates4nursesTikTok: @advocates4nursesFor more information, full transcript and videos visit Nurse.org/podcastJoin our newsletter at nurse.org/joinInstagram: @nurse_orgTikTok: @nurse.orgFacebook: @nurse.orgYouTube: Nurse.org
In today's episode, Dr. Pierce Salguero sits down with Miguel Farias, an experimental psychologist and researcher of religion, spirituality, and cognition. Together we try to get to the bottom of whether meditation is actually good for you through a comparison of Miguel's research on the adverse effects of meditation with my research on Asian notions of meditation sickness. Along the way, we discuss the limitations of modern Western understandings of consciousness, and explore whether we can develop a more expansive, multifaceted understanding of altered states both pleasant and unpleasant. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. You can also check out our members-only benefits on blackberyl.substack.com. Enjoy the show! Resources mentioned: Miguel Farias and Catherine Wikholm, The Buddha Pill: Can Meditation Change You? (2019). Miguel Farias, Oxford Handbook of Meditation (2022). Miguel Farias et al, “Adverse Events in Meditation Practices and Meditation-based Therapies: A Systematic Review” (2021). Pierce Salguero, “‘Meditation Sickness' in Medieval Chinese Buddhism and the Contemporary West” (2023). Peter Berger, The Homeless Mind (1973). Joseph Henrich et al. article on the Müller-Lyer illusion (2010). The source for the term “monophasic bias” is apparently Charles Laughlin's chapter “Transpersonal Anthropology” in Roger Walsh's book Paths Beyond Ego (1993). Pierce Salguero, A Lamp Unto Yourself (2025). Resources provided by the interviewee on blackberyl.substack.com: Introduction to the Oxford Handbook of Meditation Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine (2010), and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. www.piercesalguero.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network
In today's episode, Dr. Pierce Salguero sits down with Miguel Farias, an experimental psychologist and researcher of religion, spirituality, and cognition. Together we try to get to the bottom of whether meditation is actually good for you through a comparison of Miguel's research on the adverse effects of meditation with my research on Asian notions of meditation sickness. Along the way, we discuss the limitations of modern Western understandings of consciousness, and explore whether we can develop a more expansive, multifaceted understanding of altered states both pleasant and unpleasant. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. You can also check out our members-only benefits on blackberyl.substack.com. Enjoy the show! Resources mentioned: Miguel Farias and Catherine Wikholm, The Buddha Pill: Can Meditation Change You? (2019). Miguel Farias, Oxford Handbook of Meditation (2022). Miguel Farias et al, “Adverse Events in Meditation Practices and Meditation-based Therapies: A Systematic Review” (2021). Pierce Salguero, “‘Meditation Sickness' in Medieval Chinese Buddhism and the Contemporary West” (2023). Peter Berger, The Homeless Mind (1973). Joseph Henrich et al. article on the Müller-Lyer illusion (2010). The source for the term “monophasic bias” is apparently Charles Laughlin's chapter “Transpersonal Anthropology” in Roger Walsh's book Paths Beyond Ego (1993). Pierce Salguero, A Lamp Unto Yourself (2025). Resources provided by the interviewee on blackberyl.substack.com: Introduction to the Oxford Handbook of Meditation Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine (2010), and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. www.piercesalguero.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/buddhist-studies
In today's episode, Dr. Pierce Salguero sits down with Miguel Farias, an experimental psychologist and researcher of religion, spirituality, and cognition. Together we try to get to the bottom of whether meditation is actually good for you through a comparison of Miguel's research on the adverse effects of meditation with my research on Asian notions of meditation sickness. Along the way, we discuss the limitations of modern Western understandings of consciousness, and explore whether we can develop a more expansive, multifaceted understanding of altered states both pleasant and unpleasant. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. You can also check out our members-only benefits on blackberyl.substack.com. Enjoy the show! Resources mentioned: Miguel Farias and Catherine Wikholm, The Buddha Pill: Can Meditation Change You? (2019). Miguel Farias, Oxford Handbook of Meditation (2022). Miguel Farias et al, “Adverse Events in Meditation Practices and Meditation-based Therapies: A Systematic Review” (2021). Pierce Salguero, “‘Meditation Sickness' in Medieval Chinese Buddhism and the Contemporary West” (2023). Peter Berger, The Homeless Mind (1973). Joseph Henrich et al. article on the Müller-Lyer illusion (2010). The source for the term “monophasic bias” is apparently Charles Laughlin's chapter “Transpersonal Anthropology” in Roger Walsh's book Paths Beyond Ego (1993). Pierce Salguero, A Lamp Unto Yourself (2025). Resources provided by the interviewee on blackberyl.substack.com: Introduction to the Oxford Handbook of Meditation Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine (2010), and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. www.piercesalguero.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/psychology
In today's episode, Dr. Pierce Salguero sits down with Miguel Farias, an experimental psychologist and researcher of religion, spirituality, and cognition. Together we try to get to the bottom of whether meditation is actually good for you through a comparison of Miguel's research on the adverse effects of meditation with my research on Asian notions of meditation sickness. Along the way, we discuss the limitations of modern Western understandings of consciousness, and explore whether we can develop a more expansive, multifaceted understanding of altered states both pleasant and unpleasant. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. You can also check out our members-only benefits on blackberyl.substack.com. Enjoy the show! Resources mentioned: Miguel Farias and Catherine Wikholm, The Buddha Pill: Can Meditation Change You? (2019). Miguel Farias, Oxford Handbook of Meditation (2022). Miguel Farias et al, “Adverse Events in Meditation Practices and Meditation-based Therapies: A Systematic Review” (2021). Pierce Salguero, “‘Meditation Sickness' in Medieval Chinese Buddhism and the Contemporary West” (2023). Peter Berger, The Homeless Mind (1973). Joseph Henrich et al. article on the Müller-Lyer illusion (2010). The source for the term “monophasic bias” is apparently Charles Laughlin's chapter “Transpersonal Anthropology” in Roger Walsh's book Paths Beyond Ego (1993). Pierce Salguero, A Lamp Unto Yourself (2025). Resources provided by the interviewee on blackberyl.substack.com: Introduction to the Oxford Handbook of Meditation Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine (2010), and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. www.piercesalguero.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/religion
In today's episode, Dr. Pierce Salguero sits down with Miguel Farias, an experimental psychologist and researcher of religion, spirituality, and cognition. Together we try to get to the bottom of whether meditation is actually good for you through a comparison of Miguel's research on the adverse effects of meditation with my research on Asian notions of meditation sickness. Along the way, we discuss the limitations of modern Western understandings of consciousness, and explore whether we can develop a more expansive, multifaceted understanding of altered states both pleasant and unpleasant. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. You can also check out our members-only benefits on blackberyl.substack.com. Enjoy the show! Resources mentioned: Miguel Farias and Catherine Wikholm, The Buddha Pill: Can Meditation Change You? (2019). Miguel Farias, Oxford Handbook of Meditation (2022). Miguel Farias et al, “Adverse Events in Meditation Practices and Meditation-based Therapies: A Systematic Review” (2021). Pierce Salguero, “‘Meditation Sickness' in Medieval Chinese Buddhism and the Contemporary West” (2023). Peter Berger, The Homeless Mind (1973). Joseph Henrich et al. article on the Müller-Lyer illusion (2010). The source for the term “monophasic bias” is apparently Charles Laughlin's chapter “Transpersonal Anthropology” in Roger Walsh's book Paths Beyond Ego (1993). Pierce Salguero, A Lamp Unto Yourself (2025). Resources provided by the interviewee on blackberyl.substack.com: Introduction to the Oxford Handbook of Meditation Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine (2010), and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. www.piercesalguero.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/spiritual-practice-and-mindfulness
Ashley Everly is a Toxicologist and the founder of Vaccine.Guide, a one-stop resource on research and information regarding vaccines and the infectious diseases they aim to prevent. In this conversation with Ashely we discuss:The adverse event that led her to investigate vaccinesDiscovering that there is no "happy medium"The woefully inadequate safety studies done on vaccinesThe issue(s) with aluminum adjuvantsOther problematic ingredients...and more!Learn more about Ashley and her work at https://vaccine.guide/ or at https://everlyreport.com/.Support Terrain Theory on Patreon! Our recently-launched member platform gives you access to a ton of free & exclusive content. Check it out: https://www.patreon.com/TerrainTheoryTerrain Theory episodes are not to be taken as medical advice. You are your own primary healthcare provider.If you have a Terrain Transformation story you would like to share, email us at ben@terraintheory.net.Learn more at www.terraintheory.netMusic by Chris Merenda
Featuring perspectives from Dr Kathleen N Moore, Dr David M O'Malley and Dr Alessandro D Santin, moderated by Dr O'Malley, including the following topics: Introduction (0:00) Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Santin (2:17) Available Data with and Practical Application of HER2-Targeted Therapy for Advanced Gynecologic Cancers — Dr O'Malley (30:24) Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr Moore (1:01:53) CME information and select publications
Today I sit down with Miguel Farias, an experimental psychologist and researcher of religion, spirituality, and cognition. Together we try to get to the bottom of whether meditation is actually good for you through a comparison of Miguel's research on the adverse effects of meditation with my research on Asian notions of meditation sickness. Along the way, we discuss the limitations of modern Western understandings of consciousness, and explore whether we can develop a more expansive, multifaceted understanding of altered states both pleasant and unpleasant.If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. You can also check out our members-only benefits on blackberyl.substack.com. Enjoy the show!Resources mentioned:Miguel Farias and Catherine Wikholm, The Buddha Pill: Can Meditation Change You? (2019).Miguel Farias, Oxford Handbook of Meditation (2022).Miguel Farias et al, “Adverse Events in Meditation Practices and Meditation-based Therapies: A Systematic Review” (2021).Pierce Salguero, “‘Meditation Sickness' in Medieval Chinese Buddhism and the Contemporary West” (2023). Peter Berger, The Homeless Mind (1973).Joseph Henrich et al. article on the Müller-Lyer illusion (2010).The source for the term “monophasic bias” is apparently Charles Laughlin's chapter “Transpersonal Anthropology” in Roger Walsh's book Paths Beyond Ego (1993).Pierce Salguero, A Lamp Unto Yourself (2025).Resources provided by the interviewee on blackberyl.substack.com:Introduction to the Oxford Handbook of Meditation
Guest: Amber Salter, PhD A recent study examined the association between comorbidities, adverse events, and early trial discontinuation in phase III clinical trials for disease-modifying therapies for multiple sclerosis. Join Dr. Amber Salter as she explains her findings and implications for clinical practice, including personalized treatment approaches. Dr. Salter is an Associate Professor of Biostatistics at UT Southwestern Medical Center, and she presented on this research at the ACTRIMS Forum 2025.
In this episode, Dr. Stephen Hussey challenges the mainstream view of heart health, explaining why the heart is not a pump and how blood actually moves through the body. He explores the real causes of heart disease, the impact of structured water on vascular health, and how the heart influences the human biofield and soul connection. Dr. Hussey also discusses the negative effects of common heart medications and why heart-related issues have been increasing in recent years. For more details, links, and resources mentioned in this episode, visit our website: https://thewayfwrd.com To watch, visit YouTube: https://youtu.be/KL68_0b-nrg Connect with Dr. Stephen Hussey: Website – https://resourceyourhealth.com/ Use code WAYFORWARD for 15% off courses Related Link: Explaining the Mechanism of Adverse Events from Covid mRNA Injections and How to Heal from Them https://resourceyourhealth.com/explaining-the-adverse-events-from-covid-mrna-injections-and-how-to-heal-from-them/ The Way Forward podcast is sponsored by: New Biology Clinic: Experience individually tailored terrain-based health services with virtual consults, practitioner livestreams, movement classes, and more. The New Biology Clinic's motivation is to make you healthy and keep you that way. Visit https://NewBiologyClinic.com and enter code TheWayForward for $50 off your activation fee. Members of The Way Forward get the full activation fee waived. Become a member of The Way Forward here: https://thewayfwrd.com/membership-sign-up/ ————————— RMDY Collective: Dedicated to making homeopathy accessible with high-quality remedies and hands-on training. Discover how this holistic approach supports natural healing and empowers you to take charge of your wellness. Explore more at RMDY Collective at https://rmdycollective.org/?bg_ref=MKho6KZowa Enroll in RMDY Academy at https://rmdyacademy.org/?bg_ref=MKho6KZowa ————————— RA Optics: Block harmful blue light during the day and at night, optimize your biology with RA Optics. Their lenses are developed with leading experts, using advanced light-filtering technology, and their handcrafted frames offer both quality and style. Check out Raoptics.com/twf10 and get 10% off your order. ————————— Confluence 2025: Confluence 2025 is a transformative gathering on a regenerative farm near San Antonio, TX, where community, health, and freedom meet. Join us for workshops, live music, and a chance to connect deeply with nature. Use promo code TWF10 for a 10% discount on your tickets. Join us at https://www.confluenceevent.com/
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist. Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study - doi.org/10.3899/jrheum.2024-0165 Potentially Avoidable Emergency Department Utilization by Persons With Psoriatic Arthritis and Ankylosing Spondylitis: A Population-Based Cohort Study - doi.org/10.3899/jrheum.2024-1113 Mortality in Patients With Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors - doi.org/10.3899/jrheum.2024-1033 Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events - doi.org/10.3899/jrheum.2024-0612 Improving Gout Care in a Canadian Academic Medical Center Through a Multidisciplinary Nurse-Led Protocol - doi.org/10.3899/jrheum.2024-0707
This special issue of JACC is dedicated to the essential role of cardiovascular surgery in advancing modern cardiology.
Anesthesia and Critical Care Reviews and Commentary (ACCRAC) Podcast
In this 302nd episode I interview Dr. David Broussard, a cardiac anesthesiologist and Chair of Anesthesiology at Ochsner Medical Center in New Orleans. We discuss his approach to preparing for, and dealing with, adverse events and how to communicate about them to patients and families in a way that builds trust. Our Sponsors:* Check out Factor: https://factormeals.com/accrac50offAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
If you've ever felt frustrated by the fear-driven legal landscape of medicine, this conversation will change the way you think about liability and the future of patient safety. In this episode, Dr. Pensa sits down with trailblazer Richard Boothman, JD, a pioneer in patient safety and transparency, to discuss how the traditional "deny and defend" approach has failed both doctors and patients. We discuss the "Michigan Model," how it came to be, how it works, and how new CMS and ACGME changes may make it our new normal. Stick around to the end, because Rick's got a story about this model in action that rivals any closing arguments. Mentioned: A World of Hurt: How Medical Malpractice Fails Everyone And sign up here for the first-of-its-kind LEAP: Litigation Education and Performance program for clinicians with Dr. Pensa. The course starts March 17 and registration ends on March 10, 2025!
Featuring slide presentations and related discussion from Dr Joyce O'Shaughnessy, Dr Mark Pegram and Prof Peter Schmid, including the following topics: Strategies to Identify Patients with HER2-Low and HER2-Ultralow Breast Cancer (0:00) Case: A woman in her mid 50s initially presenting with ER-positive, HER2 IHC 1+ locally advanced breast cancer who experiences progression to HER2 0 metastatic disease (20:53) Case: A woman in her early 60s with ER-positive, HER2 IHC 1+ metastatic breast cancer (mBC) who experiences disease progression 8 months after starting first-line CDK4/6 and aromatase inhibitor (29:14) Expanding the Spectrum of Targeted Therapy (38:52) Case: A woman in her early 60s with HR-positive, HER2 IHC 1+ mBC who receives fifth-line T-DXd resulting in stable disease (1:04:13) Case: A woman in her early 50s with progressive HR-positive, HER2 IHC 0 mBC and an ESR1 mutation who has ultralow HER2 expression on rebiopsy of new liver lesions (1:12:35) Identification and Management of Adverse Events with T-DXd (1:20:27) Case: A woman in her late 40s with HR-positive, HER2 IHC 2+ mBC who experienced persistent low-grade nausea with T-DXd that resolved with olanzapine (1:34:02) Case: A woman in her early 60s with ER-positive, HER2 2+ mBC who received T-DXd resulting in fatigue and asymptomatic interstitial lung disease (1:48:58) CME information and select publications
Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net. Today on the emDOCs cast with Brit Long (@long_brit), we cover immune checkpoint inhibitors and adverse events. To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play
Happy New Year! This week's episode will go over important details related to immune checkpoint inhibitors (ICIs) and immune-related adverse events (irAEs), with general management strategies for each of the most common iRAEs.
Guest: Tara Graff, DO, MS Host: Charles Turck, PharmD, BCPS, BCCCP While CAR T-cell therapy is an effective option for patients with certain blood cancers like lymphoma and myeloma, it's associated with two common adverse events: cytokine release syndrome and neurotoxicity. Given those risks, safety protocols have evolved over time to include strategies like aggressive hydration, prophylactic use of corticosteroids, early intervention with tocilizumab, and multidisciplinary care. Joining Dr. Charles Turck to share her insights into how we can lower the risks of CAR T-cell therapy is Dr. Tara Graff, a medical oncologist who leads a community-based clinical trial program at Mission Cancer and Blood in Des Moines, Iowa.
This recording features audio versions of January 2025 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Effectiveness of Track Cauterization in Reduction of Adverse Events for Lung Microwave Ablation ReadSelective Lymphatic Duct Embolization for Treatment of Thoracic Lymphatic Flow Disorders in Children: Technical Aspects and Comparison with Thoracic Duct Embolization ReadA Comparison of Postprocedural Hemoglobin in Catheter-Directed Thrombolysis versus Large-Bore Aspiration Thrombectomy for Acute Pulmonary Embolism ReadClinical Outcomes following Invasive Treatment of Femoropopliteal Artery Disease: A Retrospective Single-Center Cohort Study ReadOutcomes of Endovascular Treatment for Infectious Thoracic Aortic Diseases ReadThe Influence of Preablation Embolization Particle Size on the Size of the Microwave Ablation Zone in a Porcine Orthotopic Renal Tumor Model ReadJVIR and SIR thank all those who helped record this episode. To sign up to help with future episodes, please contact our outreach coordinator at millennie.chen.jvir@gmail.com. Host:Manbir Singh Sandhu, University of California Riverside School of MedicineAudio editor:Manbir Singh Sandhu, University of California Riverside School of MedicineOutreach coordinator:Millennie Chen, University of California Riverside School of MedicineAbstract readers:Maximillion Hayama, Duke University School of MedicineSonya Choe, University of California Riverside School of MedicineSiddak Dhaliwal, University of Missouri School of MedicineAkumbir Singh Grewal, St. George's University School of MedicineBryan Torres, University of California Riverside School of MedicineJason Hoang, The Ohio State College of MedicineSIR thanks BD for its generous support of the Kinked Wire.Contact us with your ideas and questions, or read more about about interventional radiology in IR Quarterly magazine or SIR's Patient Center.(c) Society of Interventional Radiology.Support the show
Exploring the background of fraud, manipulated data and reactions that led to vaccine skepticism and its mainstreaming, in ThePrint #̦PureScience. Sandhya Ramesh explains.
Featuring perspectives from Dr Farrukh T Awan, Dr Bita Fakhri, Dr Kerry A Rogers and Dr William G Wierda, moderated by Dr Jeff Sharman, including the following topics: Introduction (0:00) Optimizing First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD (1:44) Emerging Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Combination with Bcl-2 Inhibitors — Kerry A Rogers, MD (25:43) Optimal Management of Adverse Events with BTK and Bcl-2 Inhibitors; Considerations for Special Patient Populations — Farrukh T Awan, MD (49:20) Integration of Noncovalent BTK Inhibitors into the Management of Relapsed/Refractory CLL — Bita Fakhri, MD, MPH (1:11:52) Chimeric Antigen Receptor T-Cell Therapy and Other Novel Strategies for CLL — William G Wierda, MD, PhD (1:35:06) CME information and select publications
Please visit answersincme.com/WJM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in medical oncology discusses strategies for patient-centered management of immune-related adverse events (AEs) in patients receiving immunotherapy for nonmelanoma skin cancer (NMSC). Upon completion of this activity, participants should be better able to: Identify counseling strategies to educate patients and caregivers about AEs related to immunotherapy regimens for melanoma and NMSC; Describe monitoring schedules for short- and long-term immunotherapy-associated AEs; and Outline multidisciplinary management strategies for immunotherapy-associated AEs in dermatologic malignancies. This activity is intended for US healthcare professionals only.
Please visit answersincme.com/WJM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in medical oncology discusses strategies for patient-centered management of immune-related adverse events (AEs) in patients receiving immunotherapy for nonmelanoma skin cancer (NMSC). Upon completion of this activity, participants should be better able to: Identify counseling strategies to educate patients and caregivers about AEs related to immunotherapy regimens for melanoma and NMSC; Describe monitoring schedules for short- and long-term immunotherapy-associated AEs; and Outline multidisciplinary management strategies for immunotherapy-associated AEs in dermatologic malignancies. This activity is intended for US healthcare professionals only.
CONFIRM-2: Artificial Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: A Multi-Center International Registry
Alexandra, founder of "Just the Inserts," transforms complex medical information into accessible resources for the public. Sparked by her daughter's adverse vaccine reaction and her military background, she created a platform that helps Americans understand pharmaceutical product inserts and make informed healthcare decisions. Her investigation revealed concerning practices in the medical system, including limited adverse event reporting and diminishing standards of informed consent. Despite facing challenges when sharing FDA data, Alexandra continues to advocate for medical transparency through her new book and by building networks of healthcare providers committed to thorough patient education. Her work emphasizes the difference between current practices of rushed paperwork and true informed consent, where patients fully understand their medical choices. RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS
Send us a textPodcast episodes are fully available to paid subscribers on the M&M Substack and full video versions are free on YouTube. This episode will not be posted on YouTube due to the controversial nature of the content.About the guest: Jessica Rose, PhD is a computational biologist who has been studying and analyzing data from the Vaccine Adverse Event Responding System (VAERS) related to COVID. Episode summary: Nick and Dr. Rose discuss: Vaccine Adverse Event Responding System (VAERS); analysis of VAERS data for COVID; mRNA technology; spike protein persistence & lipid nanoparticles; common adverse events reported for the Pfizer & Moderna shots; myocarditis & menstrual irregularities; IgG4 antibodies, molecular mimicry & autoimmunity; and more.Related episodes:M&M #196: Vaccine Contamination & Fiat Science | Kevin McKernanM&M #100: Infectious Disease, Epidemiology, Pandemics, Health Policy, COVID, Politicization of Science | Jay BhattacharyaSpecial offer: Use MINDMATTERSPECIAL2 for a free 1-year premium subscription to Consensus, an AI-powered research tool that helps you find the best science, faster. ($150 value, limited-time offer).*This content is never meant to serve as medical adviceSupport the showAll episodes (audio & video), show notes, transcripts, and more at the M&M Substack Affiliates: MASA Chips—delicious tortilla chips made from organic corn and grass-fed beef tallow. No seed oils or artificial ingredients. Use code MIND for 20% off. KetoCitra—Ketone body BHB with potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off. Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for 10% off. Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase. Consensus: AI-powered academic research tool. Find & understand the best science, faster. Free 1-year premium sub with code MINDMATTERSPECIAL (exp 12.10.24) Learn all the ways you can support my efforts...
"Safe and effective." With these three words, President Biden and public health officials launched an unprecedented campaign to vaccinate the American public with a novel mRNA technology. Today, we know those words were demonstrably false.In a groundbreaking interview on the Radically Genuine Podcast, Amy Kelly, Chief Operations Officer of Daily Clout and director of the Pfizer Documents Analysis Project, reveals the chilling truth behind the clinical trials. Working with thousands of medical and scientific experts, Kelly's team analyzed over 450,000 pages of Pfizer's own data – documents the FDA initially tried to hide from the public for 75 years.What they uncovered is nothing short of shocking. She is the co-author of The Pfizer Papers: Pfizer's Crimes Against Humanity RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS
Today's podcast focuses on the role of BTK inhibitors (BTKis) in the treatment of mantle cell lymphoma (MCL). You will... The post Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events appeared first on VJHemOnc.
We have a great round up of some current events and topics that are not getting talked about enough. We chat about the Knife Grab in Manitoba, and the mystery of Samson consultants who got 9 million in 2024 for the Buyback bill for consulting. The Canadian Government consulting business is a tangled web. We chat about some suspect job openings as part of LMIA, the lack of knack, foreign money flowing fast out of Canada, PBO and the latest carbon tax bull crap. Edmonton's 15 minute city is coming to life - I thought that was just a conspiracy, Doctors hesitant with the MAID service. We also talk about a personal story with the Jab mandates still going on in BC and the amount of jabs you need to correct Adverse Events from Covid jab with jabs of steroids. Its quite dystopian. More Ivermectin cancer stories, good news on multiple fronts from Peter Sweden, MS starting up 3 mile island for ai based on ai, the Red List, and the Australian movement on the Covid 19 jabs. To gain access to the second half of show and our Plus feed for audio and podcast please clink the link http://www.grimericaoutlawed.ca/support. For second half of video (when applicable and audio) go to our Substack and Subscribe. https://grimericaoutlawed.substack.com/ or to our Locals https://grimericaoutlawed.locals.com/ or Rokfin www.Rokfin.com/Grimerica Patreon https://www.patreon.com/grimericaoutlawed Support the show directly: https://grimerica.ca/support-2/ Outlawed Canadians YouTube Channel: https://www.youtube.com/@OutlawedCanadians Our Adultbrain Audiobook Podcast and Website: www.adultbrain.ca Our Audiobook Youtube Channel: https://www.youtube.com/@adultbrainaudiobookpublishing/videos Darren's book www.acanadianshame.ca Check out our next trip/conference/meetup - Contact at the Cabin www.contactatthecabin.com Other affiliated shows: www.grimerica.ca The OG Grimerica Show www.Rokfin.com/Grimerica Our channel on free speech Rokfin Join the chat / hangout with a bunch of fellow Grimericans Https://t.me.grimerica https://www.guilded.gg/chat/b7af7266-771d-427f-978c-872a7962a6c2?messageId=c1e1c7cd-c6e9-4eaf-abc9-e6ec0be89ff3 Get your Magic Mushrooms delivered from: Champignon Magique Get Psychedelics online Leave a review on iTunes and/or Stitcher: https://itunes.apple.com/ca/podcast/grimerica-outlawed http://www.stitcher.com/podcast/grimerica-outlawed Sign up for our newsletter http://www.grimerica.ca/news SPAM Graham = and send him your synchronicities, feedback, strange experiences and psychedelic trip reports!! graham@grimerica.com InstaGRAM https://www.instagram.com/the_grimerica_show_podcast/ Purchase swag, with partial proceeds donated to the show www.grimerica.ca/swag Send us a postcard or letter http://www.grimerica.ca/contact/ ART - Napolean Duheme's site http://www.lostbreadcomic.com/ MUSIC Tru Northperception, Felix's Site sirfelix.bandcamp.com See links to stuff we chatted about during the show: https://www.petersweden.org/p/it-happened-norway-just-rejected?utm_source=post-email-title&publication_id=547128&post_id=149888588&utm_campaign=email-post-title&isFreemail=true&r=24pqe&triedRedirect=true&utm_medium=email https://www.petersweden.org/p/bombshell-slovakia-could-ban-mrna?utm_source=post-email-title&publication_id=547128&post_id=150073127&utm_campaign=email-post-title&isFreemail=true&r=24pqe&triedRedirect=true&utm_medium=email https://www.instagram.com/p/DAM7NvVNoxW/ https://x.com/LeilaniDowding/status/1846556404707934579 https://x.com/Tablesalt13/status/1845665276118876367 https://x.com/SaiKate108/status/1845353260166910053 https://x.com/Mill_Moron/status/1844841736595743012 https://x.com/Tablesalt13/status/1844752664195690594 https://x.com/NyaPfanner/status/1844455593635115237 https://x.com/RetroCoast/status/1841648255790178762 https://x.com/TWilsonOttawa/status/1841860474247242097 Darren's links: https://news.gov.mb.ca/news/index.html?item=65497 https://www.theepochtimes.com/world/canadian-households-worse-off-overall-under-carbon-tax-pbo-report-finds-for-second-time-5739094?utm_source=BN_article_paid&src_src=BN_article_paid&utm_campaign=breaking-2024-10-10-ca&src_cmp=breaking-2024-10-10-ca&utm_medium=email&est=LMpKF3%2FPE9SNgMpyItwgFzL0bZyZbWISpoTCWDQGA6RjhVz2YTxUWmNNiDTv2%2BzM&utm_term=news3&utm_content=3 https://www.newswire.ca/news-releases/millions-more-ontarians-will-live-with-major-illness-by-2040-851491514.html#:~:text=This%20study%20combined%20age%20and,from%201.8%20million%20in%202020. https://www.theepochtimes.com/world/private-forums-show-canadian-doctors-struggle-with-euthanizing-vulnerable-patients-5742397?utm_source=NA_article_paid&src_src=NA_article_paid&utm_campaign=newsalert-2024-10-16-ca&src_cmp=newsalert-2024-10-16-ca&utm_medium=email&est=2qw2dkZe%2F1AepjhhABAmN%2Fe%2FbKbBjgF2y%2Fpg4SAzbUxEzL2rRtsOMaukCsp21I4E&utm_term=news4&utm_content=4 https://www.theepochtimes.com/world/how-edmontons-15-minute-city-plan-may-play-out-5737582?utm_source=TOP5_article_paid&src_src=TOP5_article_paid&utm_campaign=top5-2024-10-12-ca&src_cmp=top5-2024-10-12-ca&utm_medium=email&est=Lac6axs4hYBUrgRMMvTdf5tpw2EF9O4AAIXG0o6lYM17UFXb7RFZ8LYOk7ZekKd1 https://www.theepochtimes.com/epochtv/why-an-emp-attack-is-worse-than-you-think-facts-matter-5730122?utm_source=TOP5_article_paid&src_src=TOP5_article_paid&utm_campaign=top5-2024-10-12-ca&src_cmp=top5-2024-10-12-ca&utm_medium=email&est=zcQdqLW%2FhfAlu2GfTwaTanU0kzzlgRtHMp%2F3m9WNNrl1UX1cXVbT6q5ytOQAZoFc https://x.com/ChildrensHD/status/1845970362971853192 https://petermcculloughmd.substack.com/p/longcovid-19-fatigue-skyrockets-among?utm_campaign=email-half-post&r=2at6hc&utm_source=substack&utm_medium=email https://makismd.substack.com/p/ivermectin-testimonial-thyroid-cancer?utm_source=post-email-title&publication_id=1385328&post_id=150251268&utm_campaign=email-post-title&isFreemail=false&r=2at6hc&triedRedirect=true&utm_medium=email
Dr. Sardari Nia's trial on digital cardiac counseling, presented at EACTS and published in JACC, is a randomized study of 394 patients. It investigated the impact of telemedicine-based prehabilitation to reduce modifiable risk factors in patients awaiting elective cardiac surgery. The results demonstrated a significant 35% reduction in major adverse events, particularly rehospitalizations, highlighting the safety and effectiveness of prehabilitation in improving patient outcomes. This trial also emphasizes empowering patients to take control of their health before surgery, potentially benefiting healthcare on a larger scale.
Audrey Neff speaks with Coverwell CEO, Patrick Tighe, and CMO, Kandis Hughes, to discuss maintaining integrity and ensuring patient safety in the medical aesthetics industry. Throughout the episode, the three delve into the prevalence and nature of adverse events within the elective medical field, highlighting the often unforeseen complications and the gap in patient care that needs addressing. This candid discussion underscores the significance of setting patient expectations, informed consent, proper education, thorough screening processes, and the essential defensive measures practices should adopt—emphasizing the role of businesses like Coverwell in providing a safety net for both practitioners and patients.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.
In this episode, we explore a recent study challenging the safety concerns surrounding haloperidol use in older patients post-surgery. We discuss its implications for managing delirium and compare it to other antipsychotics. Could haloperidol be the unsung hero in our psychopharmacological arsenal? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 59 Comparative Safety of Oral Antipsychotics for Adverse Events in Adults After Surgery
Ophthalmologists are not spared from the opioid epidemic. Recent studies have shown that opioids continue to be prescribed after ophthalmic surgeries. Dr. Drew Carey interviews Dr. Matthew R. Starr on his retrospective study published in Ophthalmology, “Hospitalization, Overdose, and Mortality After Opioid Prescriptions Tied to Ophthalmic Surgery.” Hospitalization, Overdose, and Mortality After Opioid Prescriptions Tied to Ophthalmic Surgery. Thao, Viengneesee et al. Ophthalmology, Volume 131, Issue 8, 943 – 949. Join Ophthalmology's Editor-in-Chief, Russell Van Gelder, as he presents “The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family” in Chicago at AAO 2024 on Sunday October 20, 2024, at 2pm local time in McCormick Place South Building Room S406A. Search “SYM48” in the Mobile Meeting Guide for more information.
Click here to view the full activity and claim free NCPD credit! https://i3health.com/course-information/managing-immune-related-adverse-events-to-ensure-optimal-cancer-immunotherapy-outcomes-the-nurses-view At last year's Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit, i3 Health hosted a nursing continuing professional development (NCPD) symposium entitled Managing Immune-Related Adverse Events to Ensure Optimal Cancer Immunotherapy Outcomes (IRAEs): The Nurse's View, chaired by Blanca Ledezma, MSN, NP, AOCNP®, Hematology/Oncology Nurse Practitioner at UCLA Health. With numerous advances in the immunotherapy space occurring since the symposium was held, Oncology Data Advisor Editorial Board member Beth Sandy, MSN, CRNP, Outpatient Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer Center, sat down to discuss some of these updates in lung cancer and her own insights on optimal management of IRAEs from the nursing perspective.
Interview with David B. Yaden, PhD, and Jared T. Hinkle, MD, PhD, authors of Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Adverse Events in Studies of Classic Psychedelics
Interview with David B. Yaden, PhD, and Jared T. Hinkle, MD, PhD, authors of Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Adverse Events in Studies of Classic Psychedelics
On Episode 43 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the August 2024 issue of Stroke: “Diagnostic Accuracy of Posterior/Anterior Periventricular WMH Ratio to Differentiate CAA From Hypertensive Arteriopathy” and “Statin Overuse in Cerebral Ischemia Without Indications: Systematic Review and Annual US Burden of Adverse Events.” She also interviews Dr. Gang Li about the article “Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke,” published in The New England Journal of Medicine. For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20240726.908961
Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/african-american-studies
Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/latino-studies
Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network
In this journal club episode, my guest is Dr. Peter Attia, M.D., a Stanford and Johns Hopkins-trained physician focusing on healthspan and lifespan and the host of The Drive podcast. We each present a peer-reviewed scientific paper chosen because it contains novel, interesting, and actionable data. First, we discuss a paper on how bright light exposure at sunrise and throughout the day and dark exposure at night independently improve mental health and can offset some of the major symptoms of mental health disorders such as depression and anxiety. Then, we discuss an article that explores a novel class of immunotherapy treatments to combat cancer. We also discuss some of the new data on low-calorie sweeteners and if they are safe. This episode should be of interest to listeners curious about maximizing their vitality and longevity and to anyone seeking science-supported ways to improve mental health and lifespan. For show notes, including referenced articles and additional resources, please visit hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Eight Sleep: https://www.eightsleep.com/huberman BetterHelp: https://betterhelp.com/huberman Joovv: https://joovv.com/huberman LMNT: https://drinklmnt.com/huberman Momentous: https://livemomentous.com/huberman Timestamps (00:00:00) Dr. Peter Attia, Journal Club (00:02:40) Sponsors: Eight Sleep, BetterHelp & Joovv (00:07:14) Light, Dark & Mental Health; Retina (00:11:16) Outdoor vs. Indoor Light, Cataracts, Sunglasses (00:16:17) Tools: Sunrise & Sunsets, Circadian Rhythm; Midday Light (00:24:55) Tools: Night & Light Exposure; Waking Before Sunrise (00:31:05) Article #1, Light/Dark Exposure & Mental Health (00:36:50) Sponsor: AG1 (00:38:18) Odds Ratio, Hazard Ratio (00:45:43) Night vs. Daylight Exposure, Mental Health Disorders (00:51:35) Major Depression & Light Exposure; Error Bars & Significance (00:59:15) Sponsor: LMNT (01:00:39) Prescriptions; Environmental & Artificial Light; Red Lights (01:08:14) Nighttime Light Exposure; Sleep Trackers & Belief Effects (01:13:54) Light Directionality, Phone, Night (01:17:21) Light Wavelengths & Sensors; Sunglasses (01:20:58) Hawthorne Effect, Reverse Causality, Genetics (01:26:26) Artificial Sweeteners, Appetite (01:31:16) Natural Light Cycles, Circadian Rhythm & Mental Health (01:39:53) Article #2, Immune System & Cancer (01:43:18) T-Cell Activation; Viruses (01:50:41) Autoimmunity; Cancer & Immune System Evasion (02:00:09) Checkpoint Inhibitors, CTLA-4 (02:06:45) Anti-CTLA-4 Study Drug (Ipilimumab), Melanoma (02:12:07) Patient Population, Randomization, GP100 (02:18:09) Response Rate (02:22:52) Overall Survival & Response (02:28:38) Median Survival vs. Overall Survival, Drug Development (02:35:45) Gender & Dose (02:40:32) Adverse Events; Autoimmunity (02:46:42) Pancreatic Cancer; Aging & Immune System Health (02:53:57) Melanoma; Lynch Syndrome, Keytruda (02:58:43) Immunotherapy & Cancer Treatment; Melanoma Risk (03:06:26) Zero-Cost Support, Spotify & Apple Reviews, YouTube Feedback, Sponsors, Momentous, Social Media, Neural Network Newsletter Disclaimer
© 2020-2025 Ivy Podcast Discovery LLC
